Androgen deprivation therapy in unlikely to be effective for treatment of COVID-19

M. E. O'Callaghan, A. Jay, G. Kichenadasse, K. L. Moretti

Research output: Contribution to journalComment/debate

8 Citations (Scopus)


Recent literature has reported that patients with prostate cancer treated with androgen deprivation therapy (ADT) have a lower incidence of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), an observation which has been widely reported by media outlets...
Original languageEnglish
Pages (from-to)1780-1782
Number of pages3
JournalAnnals of Oncology
Issue number12
Publication statusPublished - Dec 2020


  • Androgen deprivation therapy
  • SARS-COV-2
  • COVID-19

Cite this